This is the login page for PHARMA JAPAN WEB subscribers. PHARMA JAPAN WEB offers excerpts of some articles for free, but paid subscription is required to read full articles.

Today's Headlines RSS

BUSINESS

Japan to See Grueling Battle for Free-Price Viagra Generics

The curtain is rising on stiff competition in the Viagra (sildenafil) generic market as a throng of generic makers have won approval for their versions of Pfizer’s blockbuster erectile dysfunction ... > Read full story
REGULATORY
Generic Use Promotion Best Possible Way for Reducing Social Welfare Expenses: LDP Kono (Aug.20)
BUSINESS
Launch of Daiichi Sankyo Espha’s Cravit Generics Not Yet Determined (Aug.20)
ORGANIZATION
NEDO, NCC, Toray to Jointly Develop Simple Test Systems for Cancers and Dementia (Aug.20)
BUSINESS
Daiichi Sankyo Starts PIII Study of Etanercept Biosimilar, Eying Approval in FY2016 (Aug.20)
BUSINESS
Approval Conditions Lifted for Tykerb: GSK (Aug.20)
> More Latest News

Photosmore

  
Generic Use Promotion Best Possible Way for Reducing Social Welfare Expenses: LDP Kono (Aug.20)MHLW Drug Evaluation Head Eyes Flexible Designation Criteria for New Fast-Track Review System (Aug.19)Genzyme Japan Appoints Former Bausch & Lomb Japan President Ashikaga as Its New President (Aug.18)
  
PMDA Will Prosper by Promoting Review Work, Research, and Training Together: Chief Executive (Aug.13)Fair Discussions Necessary for Full Introduction of New Drug Development Premium: Chuikyo Member (Aug.12)Drug Price Settlement Rate Will Rise towards Sept.: JPWA Chief (Aug.11)

News Categories

REGULATORY
   Generic Use Promotion Best Possible Way for Reducing Social Welfare Expenses: LDP Kono(Aug.20)
   MHLW Drug Evaluation Head Eyes Flexible Designation Criteria for New Fast-Track Review System(Aug.19)
   Emergency Use of Favipiravir to Be Permitted if Domestic Outbreak of Ebola Occurs: Health Minister(Aug.19)
BUSINESS
   Japan to See Grueling Battle for Free-Price Viagra Generics(Aug.20)
   Launch of Daiichi Sankyo Espha’s Cravit Generics Not Yet Determined(Aug.20)
   Daiichi Sankyo Starts PIII Study of Etanercept Biosimilar, Eying Approval in FY2016(Aug.20)
ORGANIZATION
   NEDO, NCC, Toray to Jointly Develop Simple Test Systems for Cancers and Dementia(Aug.20)
   Fair Discussions Necessary for Full Introduction of New Drug Development Premium: Chuikyo Member(Aug.12)
   Drug Price Settlement Rate Will Rise towards Sept.: JPWA Chief(Aug.11)
ACADEMIA
   Chiba Univ. Once Again Advises Authors to Withdraw Papers from VART Study(Aug.19)
   Japanese Circulation Society Issues Warning Letter to Dr Matsubara and Co-Authors in Connection with Diovan Scandal(Aug.15)
   JSH to Adopt Tougher COI Rule after Panel Said Novartis’s Involvement in SIGN Trial Should Have Been Disclosed at Conference(Aug.05)

Commentary

Japanese Drug Makers Working to Increase Pace of Drug Discovery by Optimizing Operations at Research Centers

Lexicon

Drug requiring guidance:
要指導医薬品

The Column

Taking Pride in Small Things Makes Big Things Possible

Archives

MHLW Drug Evaluation Head Eyes Flexible Designation Criteria for New Fast-Track Review System(Aug.19)
Pfizer Reveals First Doctor Payments amid Delays in Disclosure(Aug.19)
Emergency Use of Favipiravir to Be Permitted if Domestic Outbreak of Ebola Occurs: Health Minister(Aug.19)
Chiba Univ. Once Again Advises Authors to Withdraw Papers from VART Study(Aug.19)
Eisai Licenses Pariet Successor to Zeria(Aug.19)

Notice

 Correction:
Article entitled “Pfizer Reveals First Doctor Payments amid Delays in Disclosure” published on August 19: The amount of manuscript and writing fees is 1.08 billion yen, not 10.8 billion yen.

Most Read

1.
Health, Science...
2.
PMDA Will Prosp...
3.
Health Ministry...
4.
First Meeting o...
5.
Japan Pharma Ma...

News Calendar